Rechercher

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 229 centres au total · contact indiqué

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 222 centres au total · contact indiqué

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate cancer (mCRPC).

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 35 centres au total · contact indiqué

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adju…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Hutchinson, Kansas, United States — à 36 km · 1 153 centres au total

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by ch…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 307 centres au total · contact indiqué

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 311 centres au total

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). Pe…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 557 centres au total · contact indiqué

This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fract…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 657 centres au total

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 374 centres au total

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 1 143 centres au total · contact indiqué

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Kingman, Kansas, United States — à 28 km · 770 centres au total · contact indiqué

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Hutchinson, Kansas, United States — à 36 km · 101 centres au total · contact indiqué

Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure c…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 163 centres au total

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 567 centres au total · contact indiqué

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pa…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 31 centres au total

The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the adjuvant improves vaccine effectiveness. The study will enroll healthy adults aged 18 years and over. Participants will receive 2 injections i…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Newton, Kansas, United States — à 53 km · 16 centres au total

Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 957 centres au total

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how sa…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 129 centres au total

This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 86 centres au total · contact indiqué

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 (recurrent CDI) and…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 215 centres au total

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 36 centres au total

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 326 centres au total · contact indiqué

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 34 centres au total · contact indiqué

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapag…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Wichita, Kansas, United States — à 43 km · 852 centres au total

This is a study to evaluate the effect on LDL-C and the safety and tolerability of FDC laroprovstat/rosuvastatin in LLT-naïve patients. Laroprovstat is a small molecule that reduces the amount of LDL-C in the blood. Laroprovstat and FDC laroprovstat/rosuvastatin are being developed for the treatment…

✓ Contact✗ Revendiqué

📍 Centre le plus proche : Derby, Kansas, United States — à 54 km · 152 centres au total